Chapter 2

The publication of the CEIS Health Report, which has by now reached its
fourth edition, is the outcome of a partnership between CEIS (Faculty of
Economics, ‘Tor Vergata’ Rome University) and a few private parties who
believe in the importance of this initiative and, in particular, in the opportunity
of offering the backup of additional information to the policy makers
and the stakeholders of the health system.
This partnership aims at establishing a lasting cooperation between the
public and the private sector, within a comprehensive framework of coordinated
research activities addressing the organization of the 2008
European Meeting of Health Economics entrusted to the ‘Tor Vergata’
Rome University.
The Report has been promoted and drawn up by CEIS with a view to allowing
the Institutions to have access to the work carried out on a yearly
basis by its researchers as well as by those belonging to the network of
national and international research centers linked to CEIS by stable
cooperative relations.
The widespread circulation of the Report among health workers and
experts has been made possible by the proactive involvement of:
■ A.N.I.A. Ass. (National Association of Insurance Companies),
and a few pharmaceutical and electromedical companies:
■ Boehringer Ingelheim Italia S.p.A.,
■ GlaxoSmithKline Italia S.p.A.,
■ Johnson & Johnson Medical S.p.A., and
■ Pfizer Italia s.r.l.
All the partners share the CEIS’s convincement of the relevance and
expediency of providing the health policy makers at a central and local
level with a quantitative and independent support that might help them to
take the correct decisions in full awareness.
Besides, they have set their hopes on meeting the approval of all those
who have the Italian health system at heart.